Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17β-estradiol during the estrous cycle

Biology of Reproduction

Volumn 65, Issue 3, 2001, Pages 680-688

  Fata, J E ^a   Chaudhary, V ^a   Khokha, R ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Apoptosis; Estradiol; Mammary glands; Ovulatory cycle; Progesterone

Indexed keywords

COLLAGENASE 3; CYCLINE; ESTRADIOL; GELATINASE B; PROGESTERONE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; HORMONE SYNTHESIS; IMMUNOHISTOCHEMISTRY; MAMMARY GLAND; MORPHOMETRICS; MOUSE; NICK END LABELING; NONHUMAN; NULLIPARA; OVULATION; PRIORITY JOURNAL;

EID: 0034887735     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod65.3.680     Document Type: Article

References (52)

1. The regulation of mammary gland development by hormones, growth factors, and oncogenes
2. Regulation of development of the normal mammary gland by hormones and growth factors
3. Regulation of mammary gland growth and morphogenesis by the mammary fat pad: A species comparison
4. Side-branching in the mammary gland: The progesterone-Wnt connection
5. Tissue combination and organ culture studies in the development of the embryonic mammary gland
6. Postnatal development of the rodent mammary gland
7. TIMP-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development
8. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
9. Matrix metalloproteinases
10. Matrix metalloproteinase degradation of extracellular matrix: Biological consequences
11. Roles of the matrix metalloproteinases in mammary gland development and cancer
12. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development
13. Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis
14. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: Functions of metalloproteinases and their inhibitors
15. Matrix metalloproteinases as mediators of reproductive function
16. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution
17. Temporal and spatial expression of tissue inhibitors of metalloproteinases during the natural ovulatory cycle of the mouse
18. Lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: Correlation with circulating estradiol and progesterone
19. A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA
20. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
21. Genomic sequencing
22. PCNA: Structure, functions and interactions
23. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development
24. Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53
25. Regulation of the human menstrual cycle
26. Effect of ovarian hormones on the duration of DNA synthesis in cells of the C3H mouse mammary gland
27. Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography
28. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities
29. Estrogen receptor null mice: What have we learned and where will they lead us?
30. Progesterone receptors in the mouse mammary duct: Distribution and developmental regulation
31. Experimental mammary epithelial morphogenesis in an in vivo model: Evidence for distinct cellular progenitors of the ductal and lobular phenotype
32. The mammary gland of the mouse, during the oestrus cycle, pregnancy and lactation
33. Correlation between the effects of neuroleptic on prolactin release, mammary stimulation and the vaginal cycle in rat
34. Apoptosis in the estrous and menstrual cycles
35. Cell turnover in the "resting" human breast: Influence of parity, contraceptive pill, age and laterality
36. Topologic assessment by use of whole mounts of mitotic activity in the hamster mammary gland during the estrous cycle
37. Progesterone inhibits growth and induces apoptosis in breast cancer cells: Inverse effects on Bcl-2 and p53
38. Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland
39. Comparison of the estrous cycles in mice of high and low cancer lines
40. Role of sex steroid hormones in normal mammary gland function
41. Roles of estrogen and progesterone in normal mammary gland development
42. Growth factors, apoptosis, and survival of mammary epithelial cells
43. Matrix metalloproteinases and their expression in mammary gland
44. Modification and repression of genes expressed in the mammary gland using gene targeting and other technologies
45. Mammary gland oncogenes as indicators of pathways important in mammary gland development
46. Signal transduction in mammary tumorigenesis: A transgenic perspective
47. The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin DI in transformation of multiple tissues
48. Aromatase overexpression and breast hyperplasia, an in vivo model - Continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands
49. Dual regulation of proliferation and apoptosis: C-myc in bitransgenic murine mammary tumor models
50. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis
51. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis
52. Expression of the cytoplasmic domain of E-cadherin induces precocious mammary epithelial alveolar formation and affects cell polarity and cell-matrix integrity